搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
JD Supra
2 小时
Ozempic Weight Loss Users at Risk of Gastroparesis and Other Stomach Problems, New Study ...
A recent study published by the Journal of the American Medical Association (JAMA) found that patients taking the drugs ...
Medical News Today
5 小时
GLP-1 drugs like Ozempic may protect brain health, several studies show
A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...
1 天
Why Ozempic, Zepbound, and other weight-loss drug dupes carry risks
Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.
1 天
on MSN
Wegovy vs. Ozempic: What's the Difference Between the 2 Drugs?
The prescription drug has been all over the news in the past couple of years - but the name Ozempic has become something of a ...
1 天
on MSN
This unexpected Ozempic side effect? Wreaking havoc on women’s wardrobes: ‘The shots ...
A voguish — and often daunting — problem can plague people who have experienced recent and relatively rapid weight loss.
9 小时
on MSN
Ozempic is driving up the cost of your health care, whether you can get your hands on it or not
Health-care costs are going up and and yet, workers may still not get the coverage they want — particularly when it comes to drugs like Ozempic.
自行车网
7 天
被滥用的“减肥神药”司美格鲁肽,会出现在自行车赛场吗?
近年来兴起的新型减肥药,例如Ozempic和Wegovy,已经帮助全世界的人们减掉了超过15%的体重,它的作用之夸张,以至于沃尔玛将食品销量的下降归因于这些药物的发明和上市。因此,许多人将这种新一代药物称为社会的“游戏规则改变者”。
tyla
1 天
Difference between Ozempic, Wegovy, Mounjaro and Saxenda explained
Unlike Ozempic, Wegovy is approved for weight management even though they both contain semaglutide. However, they do have ...
2 天
on MSN
WeightWatchers offering compounded version of Ozempic, despite concerns expressed by FDA
High demand has created a market for compounded versions of the drug best known as Ozemic or Wegovy, but doctors and the FDA ...
3 天
诺和诺德就减肥药Ozempic和Wegovy专利纠纷与迈兰制药达成和解
诺和诺德与Viatris旗下迈兰制药在一份联合文件中表示,已同意解决与诺和诺德减肥药Ozempic和Wegovy相关的专利纠纷。此前诺和诺德已分别在法院起诉Viatris和其他公司侵犯专利,以阻止拟议的仿制药。诺和诺德发言人当地时间10月7日证实了和解协议。 返回搜狐,查看更多 ...
9 天
诺和诺德股票前景修正:定价压力影响Wegovy和Ozempic销售增长
周三,美银证券调整了对诺和诺德公司(NYSE:NVO)股票的展望,将目标价从之前的166.00美元下调至159.50美元,同时维持对该股票的买入评级。这一调整是因为分析师预计第三季度集团销售额将达到约694亿丹麦克朗,同比增长18%,息税前利润(EBIT)将达到约330亿丹麦克朗,较上年同期增长23%。尽管有这些增长,预测的EBIT比共识预期低约4%。
4 天
Novo Nordisk settles US patent fight with Viatris over Ozempic
Novo Nordisk and Viatris have agreed to resolve a patent dispute related to Novo's blockbuster weight-loss drugs Ozempic and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈